Could This Injection Finally Fix Cellulite?

Midlife Mayhem: CBL-514, the Injectable That Could Change Cellulite and Stubborn Fat

Is an injection, pill or potion coming for everything? This week Joanne looks at CBL-514, an experimental injectable aimed at stubborn fat and cellulite, and shows how to read a breakthrough headline without getting swept away.

🎧 In This Episode

Cellulite and stubborn fat are the two things midlife women ask about most. CBL-514 is an experimental injectable developed for both. It isn’t approved anywhere and can’t be bought, but it points to where this whole field is heading, and it makes a great case study in reading the headlines critically.

🔬 What Is CBL-514?

Developed by Taiwanese company Calaway Biopharmaceuticals

A small molecule injection (not a peptide)

Designed for non-surgical, localized fat reduction and moderate to severe cellulite

Still in clinical trials, not approved anywhere

💡 Why It’s Different: Fewer Fat Cells, Not Just Smaller Ones

Diet, training and even GLP-1 medications shrink the size of the fat cells you already have, like letting the water out of a balloon. The cell is still there, which is why weight regain is so common.

CBL-514 is proposed to induce apoptosis (programmed cell death) in fat cells, so there are fewer fat cells in a targeted area.